Back
United Therapeutics 10K Form
Buy
51
UTHR
United Therapeutics
Last Price:
358.09
Seasonality Move:
9.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-01 | 10Q | UTHR/United Therapeutics Quarterly |
2023-11-01 | 10Q | UTHR/United Therapeutics Quarterly |
2023-08-02 | 10Q | UTHR/United Therapeutics Quarterly |
2023-05-03 | 10Q | UTHR/United Therapeutics Quarterly |
2022-11-02 | 10Q | UTHR/United Therapeutics Quarterly |
2022-08-03 | 10Q | UTHR/United Therapeutics Quarterly |
Receive UTHR News And Ratings
See the #1 stock for the next 7 days that we like better than UTHR
UTHR Financial Statistics
Sales & Book Value
Annual Sales: | $2.33B |
---|---|
Cash Flow: | $187.1M |
Price / Cash Flow: | 20.06 |
Annual Sales: | $128.25 |
Price / Book: | 2.79 |
Profitability
EPS (TTM): | 21.76000 |
---|---|
Net Income (TTM): | $1.07B |
Gross Margin: | $2.07B |
Return on Equity: | 19% |
Return on Assets: | 15.69% |
United Therapeutics Earnings Forecast
Key United Therapeutics Financial Ratios
- The Gross Profit Margin over the past 25 years for UTHR is 88.94%.
- The Selling, General & Administrative Expenses for UTHR have been equal to 20.50% of Gross Profit Margin.
- The Research & Development expenses have been 17.53% of Revenue.
- The Interest Expense is 6.02% of Operating Income.
- The Net Earning history of UTHR is 42.31% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 17 years.
United Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | UTHR |
CUSIP: | 91307C |
Website: | unither.com |
Debt
Debt-to-Equity Ratio: | 0.09 |
---|---|
Current Ratio: | 4.35 |
Quick Ratio: | 3.92 |
Price-to-Earnings
Trailing P/E Ratio: | 18.06 |
---|---|
Forward P/E Ratio: | 12.92 |
UTHR Technical Analysis vs Fundamental Analysis
Buy
51
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a Buy
The current United Therapeutics [UTHR] share price is $357.83. The Score for UTHR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.